Braidlock Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Braidlock Limited - overview
Established
2002
Location
London, -, UK
Primary Industry
Medical Devices & Equipment
About
Braidlock Limited specializes in innovative catheter securement solutions, focusing on enhancing patient safety and simplifying medical line management in clinical settings through its flagship product, the Braidlock Catheter Securement Device. Braidlock Limited, founded in 2002, is based in London, UK, and focuses on developing securement solutions for medical catheters. The company raised GBP 1 million in venture financing in December 2013 from East West Capital Partners, valuing it at GBP 2. 67 million post-money.
There are no records of significant pivots in business strategy or operations, nor are there mentions of parent or subsidiary companies. Braidlock Limited develops and provides catheter securement solutions, with its flagship Braidlock Catheter Securement Device designed to secure various medical catheters and tubing. This device enhances patient safety and simplifies the management of medical lines in clinical environments. Braidlock caters to healthcare professionals in the NHS, hospitals, and private medical facilities in the UK and internationally, offering reliable solutions for catheter securement while focusing on improving patient outcomes and reducing healthcare costs.
In the most recent fiscal year 2024, Braidlock Limited reported a revenue of GBP 33,360,316. 30, while the EBITDA was recorded at GBP -1,870,267. 40. The company generates revenue through direct sales to healthcare institutions and professionals, utilizing B2B channels and partnerships within the medical sector.
Braidlock Limited plans to expand its product offerings and enhance its market presence in the coming years. The latest venture financing of GBP 1 million will support the development of new securement devices and explore opportunities in new geographic markets. As part of its strategy, Braidlock aims to enter additional international markets by 2025, leveraging its existing partnerships to facilitate distribution. These growth initiatives align with the company's objective to enhance its product range and operational capabilities.
Current Investors
East West Capital Partners
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Devices & Equipment, Biomaterials
Website
www.braidlock.com
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Braidlock Limited - timeline of key events
Braidlock Limited - financials
| Fiscal Year Ended | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | Mar 31, 2025 |
|---|---|---|---|---|---|
| Revenue (USD) | 150,751,404 | 54,969,494 | - | - | - |
| % Revenue Growth (YoY) | - | (63.5%) | - | - | - |
| EBITDA (USD) | 12,387,577 | 989,881 | - | - | - |
| Operating Income (USD) | 12,198,147 | 827,984 | - | - | - |
| Operating Margin | 8.1% | 1.5% | - | - | - |
| % EBITDA Margin | 8.2% | 1.8% | - | - | - |
| NET Income (USD) | 5,931,007 | 700,957 | - | - | - |
| % Net Margin | 3.9% | 1.3% | - | - | - |
Braidlock Limited - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.